Changeflow GovPing Pharma & Drug Safety USPTO Patent Granted for Medical Implant Sealin...
Routine Notice Added Final

USPTO Patent Granted for Medical Implant Sealing Material

Favicon for changeflow.com ChangeBridge: Patent Grants - Pharma (A61K)
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has granted a patent (US12582751B2) to CORTRONIK GMBH for a novel sealing material designed for medical implants. The material comprises a composite structure with specific components and swelling properties intended for use in medical applications.

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582751B2 to CORTRONIK GMBH for a medical implant sealing material. The patent describes a composite material consisting of three components: a biologically inert polymer, a hydrogel that swells within a first time period, and a hygroscopic matrix that swells within a shorter second time period. This innovation aims to provide improved sealing capabilities for medical implants.

This patent grant is primarily an intellectual property event and does not impose direct compliance obligations on regulated entities. However, it may impact companies involved in the development, manufacturing, or marketing of medical implants and related sealing materials by potentially affecting market exclusivity and competitive landscapes. Companies operating in this space should be aware of this granted patent and its scope.

Source document (simplified)

← USPTO Patent Grants

Sealing material for a medical implant

Grant US12582751B2 Kind: B2 Mar 24, 2026

Assignee

CORTRONIK GMBH

Inventors

Nicolas Degen, Sebastian Kaule, Sabine Illner, Stefanie Kohse, Niels Grabow, Klaus-Peter Schmitz

Abstract

A sealing material suitable for a medical implant. The material includes a composite structure of a first component, a second component and a third component. The first component includes at least one biologically inert polymer. The second component includes a hydrogel, which swells up after contact with an aqueous solution by a first volume increase within a first time period. The third component includes a hygroscopic matrix, which swells up after contact with an aqueous solution by a second volume increase within a second time period. The second time period is shorter than the first time period.

CPC Classifications

A61L 27/40 A61L 27/52 A61N 1/406 A61K 9/5115 A61K 9/5192 A61K 47/02 A61K 47/6923 A61K 41/0052 A61P 35/00

Filing Date

2020-10-07

Application No.

17768321

Claims

20

View original document →

Named provisions

Sealing material for a medical implant

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582751B2

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Drug Labeling Medical Device Manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Medical Devices
Operational domain
R&D
Topics
Pharmaceuticals Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.